What is VRTX's current stock price?

As of now, VRTX is trading at $417.21, with a daily change of -1.23%.

What are the risks associated with VRTX stock?

VRTX Key risk is its Low Risk Level, .

What is VRTX next earnings date?

VRTX next earnings report is scheduled for Nov 10, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

VRTX Stock Analysis & IQ Rating | Vertex Pharma

VRTX

Vertex Pharma

$417.21

-$5.18 | -1.23%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 519.88

MKT CAP

$ 106.97B

52W Low

$ 362.5

VOL

$ 899.61K

P/E Ratio

29.73

AVG VOL

$ 1.57M

RSI

57.16

TREND

Uptrend

alert Latest Updates

TopRated Yesterday at 12:57

AppLovin got a big nod from Deutsche Bank, which initiated coverage with a Buy rating and a $705 target. Analysts say its AI-powered advertising engine is firing on all cylinders, helping the company dominate mobile ad tec...

VRTX Stock IQ

Login to see Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VRTX Target Price

Login to display

Strengths

VRTX Rewards

Earnings are forecast to grow

VRTX Rewards

Upgraded on attractively valued

VRTX Rewards

Investors confidence is positive

VRTX Rewards

Outperform the market

Chart

$408.85 (+2.04%)

$385.65 (+8.18%)

$446.39 (-6.54%)

$490 (-14.86%)

1year

6month

3month

1month

VRTX Risk Level

VRTX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Hit 52-week low

LOW

HIGH

VRTX Analysts Opinion

VRTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

VRTX Analysts Opinion

VRTX Analysts opinion is positive and also has improved from the past 3 months

VRTX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

89%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

92%

VRTX Street Opinion

VRTX Street view is extremely bullish and have positive views on the near-term outlook

VRTX Performance Sentiment

Sentiments overview associated with VRTX events and the stock performance.

89%

11%

Positive

Negative

24 out of 27
events present

3 out of 27
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$421.39

Resistance
Price

$383.12

Current Price Range

$426.27

Show methods +

VRTX Earnings

The TTM reflects 12-month period, providing review of VRTX financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

11,419

11,020

9,869

+7.57%

Cost of Revenue

1,587

1,531

1,262

+12.14%

Gross Profit

9,832

9,490

8,607

+6.88%

Operating Exp

10,032

9,723

4,827

+44.16%

Operating Inc

-199

-233

3,780

-

Net Interest Inc

487

568

571

-7.65%

Interest Exp

17

31

44

-37.84%

Interest Inc

504

598

615

-9.47%

Other Inc Exp

4,087

-86

29

+1087.14%

EPS Growth

14.12

-2.08

14.05

+0.25%

VRTX Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.29

Next Earnings Date: Nov 10, 2025

VRTX Latest Analysis +

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?. Strong Trikafta/Kaftrio demand along with contributions from Alyftrek Casgevy and Journavx may have helped VRTX outperform in the third quarter.

Tue Oct 28, 2025

$422.39 | +0.53%

Activity

Potential

H.C. Wainwright Reiterates a Buy Rating on Vertex Pharmaceuticals (VRTX). Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on October 21 setting a price target of $478. The analyst based the optimistic rating on the positive potential of the companys kidney franchise stating that its [….]

Tue Oct 28, 2025

$422.39 | +0.53%

Rating

Vertex Pharmaceuticals Remains A Buy Heading Into Q3 Earnings.

Tue Oct 28, 2025

$422.39 | +0.53%

Rating

Step Therapy Shifts and Pipeline Momentum Reshape the Membranous Nephropathy Treatment Landscape according to Spherix Global Insights. EXTON PA Oct. 28 2025 (GLOBE NEWSWIRE) -- The membranous nephropathy (MN) treatment paradigm is on the brink of transformation with physicians signaling strong interest in novel mechanisms of action and shifting away from legacy regimens according to Spherix Global Insights'. recently published Market Dynamix™.: Membranous Nephropathy (US) 2025 service.

Tue Oct 28, 2025

$422.39 | +0.53%

Activity

Vertex (VERX) Fell Due to Lowered Guidance.

Tue Oct 28, 2025

$422.39 | +0.53%

Potential

Vertex (VERX) Earnings Expected to Grow: Should You Buy?. Vertex (VERX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mon Oct 27, 2025

$420.05 | -0.32%

Earnings

Potential

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?. Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mon Oct 27, 2025

$420.05 | -0.32%

Earnings

Potential

Wall Street Analysts Believe Vertex (VERX) Could Rally 44.47%: Heres is How to Trade. The mean of analysts price targets for Vertex (VERX) points to a 44.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Thu Oct 23, 2025

$422.63 | -0.89%

Potential

Bank of America Securities Remains ish on Vertex Pharmaceuticals Incorporated (VRTX). Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best long term low volatility stocks to buy right now. Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on October 21 with a price target of $563. The analyst based the optimistic rating on the companys strong growth potential [….]

Thu Oct 23, 2025

$422.63 | -0.89%

Potential

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It. Recently Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Wed Oct 22, 2025

$426.44 | +0.04%

Activity

FAQ About VRTX Stock Insights

What is VRTX current stock price?

What are VRTX stock strengths?

What risks are associated with VRTX stock?

When is VRTX next earnings report?

What is VRTX market cap and volume?

What is VRTX's current Stock IQ?

Should I buy VRTX stock right now?

Is VRTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for VRTX?

What does a 'Strong Sell' rating mean for VRTX?

What factors influence VRTX's Stock IQ?

Explore our VRTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored VRTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our VRTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

VRTX

Vertex Pharma

Current Price

$417.21

-$5.18 | -1.23%

52W High

$ 519.88

MKT CAP

$ 106.97B

52W Low

$ 362.5

VOL

$ 899.61K

P/E Ratio

29.73

AVG VOL

$ 1.57M

RSI

57.16

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

VRTX Rewards

Earnings are forecast to grow

VRTX Rewards

Upgraded on attractively valued

VRTX Rewards

Investors confidence is positive

VRTX Rewards

Outperform the market

VRTX Stock IQ

Login to unlock Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$408.85 (+2.04%)

$385.65 (+8.18%)

$446.39 (-6.54%)

$490 (-14.86%)

1year

6month

3month

1month

VRTX Analysts Opinion

VRTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

VRTX Analysts Opinion

VRTX Analysts opinion is positive and also has improved from the past 3 months

VRTX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

89%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

92%

VRTX Street Opinion

VRTX Street view is extremely bullish and have positive views on the near-term outlook

VRTX Risk Level

VRTX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Hit 52-week low

LOW

HIGH

VRTX Performance Sentiment

Sentiments overview associated with VRTX events and the stock performance.

89%

11%

Positive

Negative

24 out of 27
events present

3 out of 27
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$421.39

Resistance
Price

$383.12

Current Price Range

$426.27

Show methods +

VRTX Earnings

The TTM data reflects the most recent 12-month period, providing overview of VRTX financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

11,419

11,020

9,869

+7.57%

Cost of Revenue

1,587

1,531

1,262

+12.14%

Gross Profit

9,832

9,490

8,607

+6.88%

Operating Exp

10,032

9,723

4,827

+44.16%

Operating Inc

-199

-233

3,780

-

Net Interest Inc

487

568

571

-7.65%

Interest Exp

17

31

44

-37.84%

Interest Inc

504

598

615

-9.47%

Other Inc Exp

4,087

-86

29

+1087.14%

EPS Growth

14.12

-2.08

14.05

+0.25%

VRTX Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.29

Next Earnings Date: Nov 10, 2025

VRTX Latest Analysis

TopRated Yesterday at 12:57

AppLovin got a big nod from Deutsche Bank, which initiated coverage with a Buy rating and a $705 target. Analysts say its AI-powered advertising engine is firing on all cylinders, helping the company dominate mobile ad tec...

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VRTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our VRTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VRTX Stock trends

VRTX Stock performance

VRTX Stock analysis

VRTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VRTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VRTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

VRTX Stock Analysis & IQ Rating | Vertex Pharma

VRTX Stock IQ

VRTX Target Price

VRTX Risk Level

VRTX Analysts Opinion

VRTX Street Consensus

VRTX Performance Sentiment

Technical Price Levels

VRTX Financial Health

Explore our VRTX Stock insights

Receive our VRTX Daily Alerts

VRTX Stock IQ

VRTX Street Consensus

VRTX Risk Level

Technical Price Levels

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VRTX. We're here to help you make informed investment decisions today.

Receive our VRTX Daily Alerts

VRTX Runner Alarm